Order Paper

Data sources & licences Contact us

Contains Parliamentary information licensed under the Open Parliament Licence v3.0. Contains public sector information licensed under the Open Government Licence v3.0. © Parliamentary copyright. © Crown copyright.

Today Browse Your MP Calendar

Reclassify Soleve Sunburn Relief cutaneous… · Order Paper · Order Paper

Browse Consultations

CONSULT.ClosedConsultation · gov.uk

Reclassify Soleve Sunburn Relief cutaneous emulsion

MHRA is asking for feedback on proposals to reclassify Soleve Sunburn Relief Cutaneous Emulsion from pharmacy to general sales list.

Last fetched 03 May 2026 · gov.uk

Detail

The Commission on Human Medicines has advised that this product can be available as a general sales list medicine.

Documents

Reclassify Soleve Sunburn Relief cutaneous emulsionapplication/pdf

At a glance

Opened14 Jan 2015

Closes04 Feb 2015

First published14 Jan 2015

Last updated14 Jan 2015

Document typeclosed_consultation

Organisations

Medicines and Healthcare products Regulatory Agency

Topics

Patient safetyPublic health

Source

Other from medicines-and-healthcare-products-regulatory-agencySee all →

Consultation on the regulation of Gene therapy medicinal products

Draft rare disease therapies regulatory framework

MHRA consultation on statutory fees (2026)

UK Position Paper on Microbiome-Based Medicinal Products (MBMPs)

Medical devices regulations: targeted consultation on the indefinite recognition of CE marked devices

Consultation on the International Council for Harmonisation Guideline Q3E for Extractables and Leachables

Related consultations

Change in legal classification of Nurofen Express 400mg Oral Powder (ARM 86)

Change in classification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets (ARM 87)

Classification of Ibuprofen Seven Plus 200mg/5ml Oral Suspension

Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)